We have a formidable track record when it comes to turning world class research into globally adopted commercial opportunities, with our innovations contributing billions of dollars to the Australian economy annually.

Our team of IP and commercialisation experts help navigate the multifaceted commercialisation process, to maximise the impact of research. We provide tailored advice regarding intellectual property management, licensing, spin-outs and other commercialisation options. Large, complex, licensing and equity transactions are our speciality. Our licensing revenue is re-invested into the innovation eco-system, magnifying our impact and research into deep tech science.

Our commercialisation record:

As at 2019:

  • 679 patent families
  • 434 active licenses
  • $125M total value of CSIRO interest in portfolio companies
  • $2B total market capitalisation of portfolio companies
  • 462+ employees in portfolio companies
  • 175+ companies started from CSIRO technology

In FY 18/19:

  • $46M in IP revenue
  • $108M in revenue generated by portfolio companies
  • $529M in external revenue
  • $60M in capital raised by portfolio companies

Our equity portfolio

Supporting the growth of high-tech companies

Over 170 companies have been born from CSIRO technology. We currently hold equity interests in over 30 companies, who have a combined market capitalisation in excess of AUD$1 billion.

We have developed a number of commercialisation pathways to convert our IP into real outcomes and impact for Australia including licensing and assigning IP, research for equity as well as spin-outs and joint ventures.

Snapshot of our equity portfolio companies

Contact us

 
Your contact details
0 / 100
0 / 1900
You shouldn't be able to see this field. Please try again and leave the field blank.

For security reasons attachments are not accepted.